Literature DB >> 21400576

Histopathological, clinical, and electrophysiological features influencing postoperative outcomes in carpal tunnel syndrome.

Olimpio Galasso1, Massimo Mariconda, Giuseppe Donato, Giulio Di Mizio, Luca Padua, Antonio Brando, Francesco Conforti, Paola Valentino, Giorgio Gasparini.   

Abstract

Data on the outcome predictors of surgical result of carpal tunnel syndrome (CTS) is sparse and often conflicting. The purpose of this prospective comparative study was to evaluate the neurophysiologic findings and histological characteristics of the flexor tenosynovium in patients with CTS, assessing possible associations between these findings and preoperative patient status or surgical outcome. We evaluated 30 consecutive patients with a diagnosis of idiopathic CTS who were referred for surgery. Demographic data, subjective and objective data, and responses on an expanded assessment set, were collected before and 6 months after surgery. All patients underwent diagnostic neurophysiological testing prior to surgery, and histological analysis of tenosynovium specimens that were removed during surgery. Ten fresh-frozen cadavers served as controls. There was significant improvement in most of the disease specific (Boston questionnaire and Hi-Ob scale) and health generic (SF-36 questionnaire) evaluation tools used in the study at the 6-month follow-up. Vascular changes were noted in the tenosynovium of the flexor tendon of patients with CTS when compared with controls. Greater synovial vascularization was negative predictor of the SF-36's physical summary score before surgery. Bilateral presentation of symptoms and low nerve conduction velocity were negative predictors of the quality of life of patients after surgery for CTS. These findings have to be considered when discussing with patients as for the expected and desired outcomes of CTS surgery. The increased vascularization of flexor tenosynovium is associated with patients' functional status.
Copyright © 2011 Orthopaedic Research Society.

Entities:  

Mesh:

Year:  2011        PMID: 21400576     DOI: 10.1002/jor.21356

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  6 in total

1.  Sonographic measurements of subsynovial connective tissue thickness in patients with carpal tunnel syndrome.

Authors:  Margriet H M van Doesburg; Aebele Mink van der Molen; Jacqueline Henderson; Stephen S Cha; Kai Nan An; Peter C Amadio
Journal:  J Ultrasound Med       Date:  2012-01       Impact factor: 2.153

2.  Treatment outcome in patients with clinically defined carpal tunnel syndrome but normal electrodiagnostic test results: a randomized controlled trial.

Authors:  Floriaan G C M De Kleermaeker; Jan Meulstee; Franka Claes; Kristel M Kasius; Wim I M Verhagen
Journal:  J Neurol       Date:  2017-10-09       Impact factor: 4.849

3.  The Relevance of Collision Tests and Quantitative Sensory Testing in Diagnostics and Postoperative Outcome Prediction in Carpal Tunnel Syndrome.

Authors:  Magdalena Koszewicz; Mariusz Szydlo; Jerzy Gosk; Malgorzata Wieczorek; Krzysztof Slotwinski; Slawomir Budrewicz
Journal:  Front Neurol       Date:  2022-06-13       Impact factor: 4.086

4.  Tenotomy versus tenodesis in the treatment of the long head of biceps brachii tendon lesions.

Authors:  Olimpio Galasso; Giorgio Gasparini; Massimo De Benedetto; Filippo Familiari; Roberto Castricini
Journal:  BMC Musculoskelet Disord       Date:  2012-10-22       Impact factor: 2.362

5.  Impact of carpal tunnel surgery according to pre-operative abnormality of sensory conduction in median nerve: a longitudinal study.

Authors:  David Coggon; Georgia Ntani; E Clare Harris; Cathy Linaker; Richard Van der Star; Cyrus Cooper; Keith T Palmer
Journal:  BMC Musculoskelet Disord       Date:  2013-08-15       Impact factor: 2.362

6.  Determinants of Remission in Medically Treated Carpal Tunnel Syndrome: Study from Central India.

Authors:  Ajoy Sodani; Raunak Dani; Mukesh Dube; Dinesh Choukesey; Sunil Athale
Journal:  Ann Indian Acad Neurol       Date:  2018 Jan-Mar       Impact factor: 1.383

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.